Fundamentals Hub
BBLG Bone Biologics Corp
BBLG financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 19 annual and 0 of 63 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$7.23M (Jun 2025)
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(781) 552-4452
EIN
421743430
Headquarters
BURLINGTON, MA, 01803
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Bone Biologics, Corp. (2014–2015)
· AFH ACQUISITION X, INC. (2008–2014)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-2.89M
Total Assets
$4.44M
Total Equity
$3.92M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
-73.7%
Return on Assets
-65.2%
Current Ratio
8.67x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| R&D Expense | $1.06M | $2.13M | $6.91M |
| SG&A Expense | $2.17M | $2.09M | $2.52M |
| Operating Income | $-3.23M | $-4.22M | $-9.43M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Income | $121.98K | $55.66K | $1.87K |
| Other Income/Expense | $125.95K | $106.74K | $479.57K |
| Net Income | $-3.11M | $-4.11M | $-8.95M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $-2.65 | $-28.96 | $-34.01 |
| Diluted Shares | 1.17M | 252.96K | 263.14K |
| Balance Sheet | |||
| ASSETS | |||
| Other Current Assets | $10.00K | $10.00K | $10.00K |
| Current Assets | $5.80M | $3.86M | $3.74M |
| Noncurrent Assets | $0 | $0 | $0 |
| Total Assets | $5.80M | $3.86M | $3.74M |
| LIABILITIES | |||
| Accounts Payable | $417.88K | $373.04K | $360.66K |
| Current Liabilities | $418.59K | $377.71K | $831.40K |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $418.59K | $377.71K | $831.40K |
| EQUITY | |||
| Common Stock | $1.80K | $492 | $534 |
| Additional Paid-in Capital | $93.51M | $88.50M | $83.81M |
| Retained Earnings | $-88.13M | $-85.02M | $-80.91M |
| Total Equity | $5.38M | $3.48M | $2.91M |
| Total Liabilities & Equity | $5.80M | $3.86M | $3.74M |
| SUPPLEMENTAL | |||
| Shares Outstanding | 1.80M | 492.42K | 534.24K |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-2.69M | $-4.12M | $-9.56M |
| Capital Expenditures | - | - | - |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $4.70M | $4.42M | $5.04M |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $3.33M | $3.03M | $7.54M |
| Net Change in Cash | $2.01M | $298.56K | $-4.51M |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $5.33M | $3.33M | $3.03M |
| Cash per BS | - | - | - |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $5.33M | $3.33M | $3.03M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is Bone Biologics Corp profitable?
No. Bone Biologics Corp reported $-2.89M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.